Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02056132 · ClinicalTrials.gov registry record
Breath Condensate Study in Patients With Cystic Fibrosis.
A clinical trial, sponsored by University of Florida.
- Completed
- Registry status
- 50
- Enrollment target
NCT02056132 is a clinical trial that has completed, run by University of Florida. The registered enrollment target is 50 participants.
The verdict
NCT02056132 has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- 50 participants
- Enrollment target
Study Summary
There is an urgent need for a noninvasive method to diagnose bronchial infections and exacerbations in patients with Cystic Fibrosis (CF). The current method to diagnosed infections involves either collecting a sputum sample or obtaining a bronchoalveolar lavage (BAL). However, some patients cannot produce sputum. At the same time the decision of when a patient has an exacerbation continues to be very subjective. In this exploratory study, we propose a new, noninvasive method to diagnose bronchial infections and to evaluate possible markers of inflammation that can assist in a noninvasive way in the determination of exacerbations.
Interventions
- OTHER Exhaled Breath Condensate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2014-02 |
| Est. Completion | 2023-08-22 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02056132
The ClinicalTrials.gov registry entry for NCT02056132 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Exhaled Breath Condensate is the first listed.
NCT02056132 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02056132 about?
NCT02056132 is a clinical study titled "Breath Condensate Study in Patients With Cystic Fibrosis.". There is an urgent need for a noninvasive method to diagnose bronchial infections and exacerbations in patients with Cystic Fibrosis (CF). The current method to diagnosed infections involves either collecting a sputum sample or obtaining a bronchoalveolar lavage (BAL). However, some patients cannot ...
What is the current status of trial NCT02056132?
This trial is currently completed. The enrollment target is 50 participants. The study started on 2014-02. Estimated completion is 2023-08-22.
What interventions are being tested in trial NCT02056132?
The interventions under investigation include: Exhaled Breath Condensate (OTHER).
Who is sponsoring clinical trial NCT02056132?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.